<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Thu, 09 Apr 2026 01:51:24 -0400--><rss version="2.0">
    <channel>
        <title>Virax Biolabs Group Limited () SEC Filings</title>
        <link>https://ir.viraxbiolabs.com/sec-filings/annual-reports/rss</link>
        <description>Virax Biolabs Group Limited () - Annual Reports</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/viraxbiolabs/files/theme/images/logo-300px.png</url>
                <title>Virax Biolabs Group Limited Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]]]></title>
                <description><![CDATA[6 Related Documents: 20-F, EX-8.1, EX-12.1, EX-12.2, EX-13.1, EX-13.2]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-25-093260/0000950170-25-093260.pdf</link>
                <pubDate>Wed, 02 Jul 25 17:30:02 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-25-093260/0000950170-25-093260.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[6 Related Documents: 20-F, EX-8.1, EX-12.1, EX-12.2, EX-13.1, EX-13.2]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-24-099115/0000950170-24-099115.pdf</link>
                <pubDate>Tue, 20 Aug 24 16:25:21 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-24-099115/0000950170-24-099115.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NT 20-F - Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F]]></title>
                <description><![CDATA[NT 20-F]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-24-088958/0000950170-24-088958.pdf</link>
                <pubDate>Thu, 01 Aug 24 07:49:12 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-24-088958/0000950170-24-088958.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[8 Related Documents: 20-F, EX-8.1, EX-10.10, EX-10.11, EX-12.1, EX-12.2, EX-13.1, EX-13.2]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-23-027973/0000950170-23-027973.pdf</link>
                <pubDate>Wed, 14 Jun 23 16:32:48 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-23-027973/0000950170-23-027973.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[20-F - Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)]]></title>
                <description><![CDATA[5 Related Documents: 20-F, EX-12.1, EX-12.2, EX-13.1, EX-13.2]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-22-017130/0000950170-22-017130.pdf</link>
                <pubDate>Fri, 12 Aug 22 16:23:36 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-22-017130/0000950170-22-017130.pdf</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[NT 20-F - Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F]]></title>
                <description><![CDATA[NT 20-F]]></description>
                <link>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-22-013497/0000950170-22-013497.pdf</link>
                <pubDate>Fri, 29 Jul 22 16:01:30 -0400</pubDate>
                <guid>https://ir.viraxbiolabs.com/sec-filings/all-sec-filings/content/0000950170-22-013497/0000950170-22-013497.pdf</guid>
                                                                            </item>
            </channel>
</rss>